Top Biotechnology companies in Netherlands by EBITDA

This ranking features the top 10 Biotechnology companies in Netherlands ranked by EBITDA, totalling a EBITDA of USD -33.19 M, for January 15, 2025.
#
Name
EBITDA
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 688.55 M
Dec. 31, 2023 USD 45.57 -0.94%

Netherlands

2
USD 218.54 M
Dec. 31, 2023 USD 22.92 2.26%

Netherlands

3
USD 9.88 M
Dec. 31, 2023 USD 9.93 5.98%

Netherlands

4
USD -26.60 M
Dec. 31, 2023 USD 2.26 -0.44%

Netherlands

5
USD -40.42 M
Dec. 31, 2023 USD 0.98 -1.01%

Netherlands

6
USD -106.90 M
Dec. 31, 2023 USD 16.00 -2.50%

Netherlands

7
USD -154.01 M
Dec. 31, 2023 USD 39.01 -3.56%

Netherlands

8
USD -176.86 M
Dec. 31, 2023 USD 23.67 -3.70%

Netherlands

9
USD -192.28 M
Dec. 31, 2023 USD 673.61 1.66%

Netherlands

10
USD -253.10 M
Dec. 31, 2023 USD 13.23 -4.06%

Netherlands

Frequently Asked Questions
  • Which Biotechnology company in Netherlands has the highest EBITDA ?

    The Biotechnology company in Netherlands with the highest EBITDA is Qiagen N.V. (NYSE: QGEN) at USD 688.55 M.

  • Which Biotechnology company in Netherlands has the lowest EBITDA ?

    The Biotechnology company in Netherlands with the lowest EBITDA is uniQure N.V. (NasdaqGS: QURE) at USD -253.10 M.